English
REZOLUTE, INC.
EDGAR87 filing records in this dataset, filed from 2011-06-14 to 2026-10-29. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- 10.6 million Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg Source
Exact value
10615000 Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg
- Long-term debt including current maturities
- 14.3 million Unit_Standard_USD_btp0LR0f9ky9iH8I7v9IsA Source
Exact value
14286000 Unit_Standard_USD_btp0LR0f9ky9iH8I7v9IsA
- Shares outstanding
- 96.4 million Unit_Standard_shares_No0SPu3me0GhzT00Urw5Mw Source
Exact value
96405982 Unit_Standard_shares_No0SPu3me0GhzT00Urw5Mw
Reported share-count change
10.82% · 9.41 million Unit_Standard_shares_No0SPu3me0GhzT00Urw5Mw
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-29.
Financial data available through: 2026-06-30.
Coverage by financial measure
- revenue: No compatible figures in this window
- Operating income: 2 of 11 periods available· newest 2026-06-30
- Net income: 2 of 11 periods available· newest 2026-06-30
- Operating cash flow: 2 of 11 periods available· newest 2026-06-30
- Capital expenditure: Multiple units; comparison withheld· newest 2023-06-30
- Total assets: 2 of 11 periods available· newest 2026-06-30
- Total liabilities: 2 of 11 periods available· newest 2026-06-30
- Current assets: 2 of 11 periods available· newest 2026-06-30
- Current liabilities: 2 of 11 periods available· newest 2026-06-30
- Cash and cash equivalents: 2 of 11 periods available· newest 2026-06-30
- Long-term debt including current maturities: Multiple units; comparison withheld· newest 2021-06-30
- Shares outstanding: 2 of 11 periods available· newest 2026-06-30
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
−Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg 3.19 millionPrior period
−Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg 74.41 million
–
Current period
−Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg 77.6 million
–
Exact inputs and evidence
-77600000 − -74412000 = -3188000 Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg
-74412000 Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg · 2024-07-01 – 2025-06-30
Inspect prior input Prior source-77600000 Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg · 2025-07-01 – 2026-06-30
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg 4.48 millionPrior period
−Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg 69.08 million
–
Current period
−Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg 64.6 million
–
Exact inputs and evidence
-64600000 − -69075000 = 4475000 Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg
-69075000 Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg · 2024-07-01 – 2025-06-30
Inspect prior input Prior source-64600000 Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg · 2025-07-01 – 2026-06-30
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Values and sources
| Period | Series | Value(Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2025 2024-07-01 – 2025-06-30 | −Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg 74.41 million Exact valueExact value: -74412000 Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg 2024-07-01 – 2025-06-30: -74412000 Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg Inspect Net Income Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg 69.08 million Exact valueExact value: -69075000 Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg 2024-07-01 – 2025-06-30: -69075000 Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg Inspect Operating Cash Flow Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2026 2025-07-01 – 2026-06-30 | −Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg 77.6 million Exact valueExact value: -77600000 Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg 2025-07-01 – 2026-06-30: -77600000 Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg Inspect Net Income Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg 64.6 million Exact valueExact value: -64600000 Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg 2025-07-01 – 2026-06-30: -64600000 Unit_Standard_USD_Kgh0aNbRh06Ayu15Pmi8sg Inspect Operating Cash Flow Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
87 filings · 4,277 latest values · 4,277 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001509261, 1509261, ANTB, FMYY, RZLT, edgar:1509261
Also known as AntriaBio, Inc., FITS MY STYLE INC, REZOLUTE, INC., Rezolute, Inc.